Menu
A+ A A-

Some news about interdisciplinary approach into mieloma

Top Stories This Week

Surgery Breaking News

 
Lenalidomide Maintenance After ASCT Improves Overall Survival in Patients With Multiple Myeloma
By Frances Morin COPENHAGEN, Denmark -- June 15, 2016 -- Patients with multiple myeloma treated with lenalidomide as maintenance therapy following autologous stem cell transplantation (ASCT) show significant improvements in overall survival, according to a study presented here on June 10 at the...
Comments
 
|
 
Rates
 
 
Chemo Plus HSCT May Halt MS Symptoms Long-Term, But Therapy Comes With High Risks
NEW YORK -- June 14, 2016 -- A new use of chemotherapy followed by autologous haematopoietic stem cell transplantation (aHSCT) has fully halted clinical relapses and development of new brain lesions in 23 of 24 patients with multiple sclerosis (MS) for a prolonged period without the need for...
Comments
 
|
 
Rates
 
 
Oral Triple Combination Therapy Feasible for Previously Untreated Multiple Myeloma
By Lynne Lederman, PhD CHICAGO -- June 9, 2016 -- The all-oral combination of ixazomib, cyclophosphamide, and dexamethasone is active and has manageable toxicities as front-line treatment of multiple myeloma, according to a study presented here at the 2016 Annual Meeting of the American Society of...
Comments
 
|
 
Rates
 
Mesothelioma Surgery Improves Quality of Life
MAYWOOD, Ill -- June 9, 2016 -- Although surgery can prolong the lives of patients with malignant pleural mesothelioma, many patients avoid the operation for fear it will degrade their quality of life. However, a study presented at the 2016 Annual Meeting of the American Society of Clinical...
Comments
 
|
 
Rates
 
 
Upfront Autologous Stem Cell Transplantation Remains the Standard of Care in Myeloma
By Lynne Lederman, PhD CHICAGO -- June 9, 2016 -- Upfront high-dose melphalan (HDM) followed by autologous stem cell transplantation (ASCT) continues to be the standard of care for younger and healthier patients with multiple myeloma, according to a study presented here at the 2016 Annual Meeting...
Comments
 
|
 
Rates
 
 
Study Questions Cancer Link With Bone Growth Factor for Spinal Surgery
ALPHEN AAN DEN RIJN, the Netherlands -- June 8, 2016 -- Adding to previous evidence, a study based on a statewide cancer database shows no increase in cancer risk in patients undergoing spinal fusion surgery with the bone-promoting growth factor recombinant human bone morphogenetic protein (rhBMP...
Comments
 
|
 
Rates
 
Lenalidomide Maintenance Improves Over Survival After Stem Cell Transplant for Multiple Myeloma
By Walter Alexander CHICAGO -- June 6, 2016 -- Following autologous stem cell transplant (ASCT), lenalidomide maintenance therapy offers long-term disease control for patients newly diagnosed with multiple myeloma and significantly prolongs overall survival (OS), according to a study presented...
Comments
 
|
 
Rates
 
 
Genetic Variant May Help Predict Risk of Kidney Damage After Heart Surgery
WASHINGTON, DC -- June 3, 2016 -- Testing for a common genetic variant may help reveal which patients face an increased risk of developing kidney damage following heart surgery, according to a study published early online ahead of the print issue of the Journal of the American Society of Nephrology...
Comments
 
|
 
Rates
 
 
Frailty Among Young Bone Marrow Transplant Survivors Increases Risk of Death
CHICAGO -- June 3, 2016 -- The prevalence of frailty in young bone marrow transplant survivors is similar to that seen in the elderly population and frailty is associated with an increased risk of subsequent death, according to a study published online by JAMA Oncology. Smita Bhatia, MD,...
Comments
 
|
 
Rates
 
Many Patients Continue Using Opioids Months After Joint Replacement
ALPHEN AAN DEN RIJN, the Netherlands -- May 31, 2016 -- Many patients undergoing hip or knee replacement are still taking prescription opioid pain medications up to 6 months after surgery, according to a study published in the journal PAIN. Jenna Goesling, PhD, University of Michigan, Ann Arbor,...
Comments
 
|
 
Rates
back to top
Яндекс.Метрика

news

Feedback of WFSOS

Sign In or Create Account